Cargando…
Structural Based Screening of Antiandrogen Targeting Activation Function-2 Binding Site
Androgen receptor (AR) plays a critical role in the development and progression of prostate cancer (PCa). Current antiandrogen therapies induce resistant mutations at the hormone binding pocket (HBP) that convert the activity of these agents from antagonist to agonist. Thus, there is a high unmet me...
Autores principales: | Liu, Yangguang, Wu, Meng, Wang, Tianqi, Xie, Yongli, Cui, Xiangling, He, Liujun, He, Yang, Li, Xiaoyu, Liu, Mingliang, Hu, Laixing, Cen, Shan, Zhou, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284051/ https://www.ncbi.nlm.nih.gov/pubmed/30555332 http://dx.doi.org/10.3389/fphar.2018.01419 |
Ejemplares similares
-
Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
por: Tian, Xiaohong, et al.
Publicado: (2015) -
Corrigendum: Progress in antiandrogen design targeting hormone binding pocket to circumvent mutation based resistance
por: Tian, Xiaohong, et al.
Publicado: (2015) -
Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023) -
Identification of Theaflavin-3,3’-Digallate as a Novel Zika Virus Protease Inhibitor
por: Cui, Xiangling, et al.
Publicado: (2020) -
Evaluation of Potential Complications of Interstitial Lung Disease Associated With Antiandrogens Using Data From Databases Reporting Spontaneous Adverse Effects
por: Nawa, Hideki, et al.
Publicado: (2021)